| [1] |
Huang D, Sun W, Zhou Y, et al. Mutations of key driver genes in colorectal cancer progression and metastasis[J]. Cancer Metastasis Rev, 2018, 37(1): 173-187.
|
| [2] |
Piawah S, Venook AP. Targeted therapy for colorectal cancer metastases: A review of current methods of molecularly targeted therapy and the use of tumor biomarkers in the treatment of metastatic colorectal cancer[J]. Cancer, 2019, 125(23): 4139-4147.
|
| [3] |
Dragomir MP, Kopetz S, Ajani JA, et al. Non-coding RNAs in GI cancers: from cancer hallmarks to clinical utility[J]. Gut, 2020, 69(4): 748-763.
|
| [4] |
Anastasiadou E, Jacob LS, Slack FJ. Non-coding RNA networks in cancer[J]. Nat Rev Cancer, 2018, 18(1): 5-18.
|
| [5] |
Statello L, Guo CJ, Chen LL, et al. Gene regulation by long non-coding RNAs and its biological functions[J]. Nat Rev Mol Cell Biol, 2021, 22(2): 96-118.
|
| [6] |
Gil N, Ulitsky I. Regulation of gene expression by cis-acting long non-coding RNAs[J]. Nat Rev Genet, 2020, 21(2): 102-117.
|
| [7] |
Romero-Barrios N, Legascue MF, Benhamed M, et al. Splicing regulation by long noncoding RNAs[J]. Nucleic Acids Res, 2018, 46(5): 2169-2184.
|
| [8] |
武海丽, 段冰, 杜锦娥, 等. LncRNA 606938抑制结直肠癌细胞增殖[J]. 中国生物化学与分子生物学报, 2024, 40(7): 964-975.
|
| [9] |
Guan B, Chen F, Wu Z, et al. lncRNA PCGEM1 Regulates the Progress of Colorectal Cancer through Targeting miR-129-5p/SOX4 [J]. Dis Markers, 2022, 2022: 2876170.
|
| [10] |
Lv H, Lai C, Zhao W, et al. GABPB1-AS1 acts as a tumor suppressor and inhibits non-small cell lung cancer progression by targeting miRNA-566/F-box protein 47[J]. Oncol Res, 2022, 29(6): 401-409.
|
| [11] |
Li X, Wang H. Long Non-Coding RNA GABPB1-AS1 Augments Malignancy of Glioma Cells by Sequestering MicroRNA-330 and Reinforcing the ZNF367/Cell Cycle Signaling Pathway[J]. Neuropsychiatr Dis Treat, 2021, 17: 2073-2087.
|
| [12] |
孙清华, 任婕, 王亚菲, 等. LncRNA GABPB1-AS1靶向miR-497-5p在宫颈癌细胞中的免疫调控作用[J]. 中国临床研究, 2022, 35(9): 1193-1199.
|
| [13] |
Zhang D, Liu Z, Zheng N, et al. MiR-30b-5p modulates glioma cell proliferation by direct targeting MTDH[J]. Saudi J Biol Sci, 2018, 25(5): 947-952.
|
| [14] |
Zhu ED, Li N, Li BS, et al. miR-30b, down-regulated in gastric cancer, promotes apoptosis and suppresses tumor growth by targeting plasminogen activator inhibitor-1[J]. PLoS One, 2014, 9(8): e106049.
|
| [15] |
龚秀莹, 侯顺福, 赵苗苗, 等. LncRNA SNHG15通过miR-30b-3p调控COX6B1轴促进肺腺癌细胞增殖、迁移和侵袭的分子机制[J]. 南方医科大学学报, 2025, 45(7): 1498-1505.
|
| [16] |
Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249.
|
| [17] |
Zhou Z, Tan F, Pei Q, et al. lncRNA SNHG4 modulates colorectal cancer cell cycle and cell proliferation through regulating miR-590-3p/CDK1 axis[J]. Aging(Albany NY), 2021, 13(7): 9838-9858.
|
| [18] |
Lai M, Liu G, Li R, et al. Hsa_circ_0079662 induces the resistance mechanism of the chemotherapy drug oxaliplatin through the TNF-α pathway in human colon cancer[J]. J Cell Mol Med, 2020, 24(9): 5021-5027.
|
| [19] |
王健, 赵海剑, 孙静, 等. LncRNA SNHG4表达与结直肠癌预后的关系[J/OL]. 中华消化病与影像杂志(电子版), 2023, 13(3): 139-144.
|
| [20] |
Qi W, Li Z, Xia L, et al. LncRNA GABPB1-AS1 and GABPB1 regulate oxidative stress during erastin-induced ferroptosis in HepG2 hepatocellular carcinoma cells[J]. Sci Rep, 2019, 9(1): 16185.
|
| [21] |
Li Y, Zhou J, Wang J, et al. Mir-30b-3p affects the migration and invasion function of ovarian cancer cells by targeting the CTHRC1 gene[J]. Biol Res, 2020, 53(1): 10.
|
| [22] |
Gao D, Zhou Z, Huang H. miR-30b-3p Inhibits Proliferation and Invasion of Hepatocellular Carcinoma Cells via Suppressing PI3K/Akt Pathway[J]. Front Genet, 2019, 10: 1274.
|
| [23] |
Liu HT, Ma RR, Lv BB, et al. LncRNA-HNF1A-AS1 functions as a competing endogenous RNA to activate PI3K/AKT signalling pathway by sponging miR-30b-3p in gastric cancer[J]. Br J Cancer, 2020, 122(12): 1825-1836.
|